Peg Horn

Peg Horn

Director de Operaciones en REVOLUTION MEDICINES, INC. .

Fortuna: 24 M $ al 31/05/2026

63 años
Health Technology
Consumer Services
Commercial Services

Perfil

Margaret A. Horn is currently an Independent Director at Sangamo Therapeutics, Inc. since 2022.
She serves as Secretary & General Counsel at Genencor International, Inc. since 1991.
She is a Member of The State Bar of California and the Pennsylvania State Bar Association.
She is Chief Operating Officer at Revolution Medicines, Inc. since 2018.
Formerly, Ms. Horn was General Counsel & Secretary at Kosan Biosciences, Inc. from 2005 to 2007.
She was SVP-Corporate Development & General Counsel at Cogentus Pharmaceuticals, Inc. in 2009.
She worked as Principal at E.I.
du Pont de Nemours & Co. She was Chief Operating Officer at Prolynx LLC from 2010 to 2014.
Education includes undergraduate studies at the University of the Sciences in Philadelphia, graduate studies at Charles Widger School of Law, and an MBA from The Pennsylvania State University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
17/06/2026 154.647 ( 0,07 % ) 24 M $ 31/05/2026
12/06/2025 82.650 ( 0,02 % ) 18 018 $ 31/05/2026

Cargos activos de Peg Horn

EmpresasCargoInicio
REVOLUTION MEDICINES, INC. Director de Operaciones 01/10/2018
SANGAMO THERAPEUTICS, INC. Director/Miembro de la Junta 15/12/2022
Consejero General 01/01/1991
Corporate Officer/Principal -
Corporate Officer/Principal -

Antiguos cargos conocidos de Peg Horn.

EmpresasCargoFin
Director de Operaciones 01/12/2014
Consejero General 18/12/2009
Corporate Officer/Principal -
Consejero General 24/08/2007
Ver el detalle de la experiencia de Peg Horn.

Formación de Peg Horn.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

81

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

Consumer Services

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN